ClinicalTrials.Veeva

Menu

Intra-articular Injection: A Innovational Approach for Joint Disorder

M

Muhammad

Status

Not yet enrolling

Conditions

Temporomandibular Joint Dysfunction

Treatments

Behavioral: Routine rehabilitation treatment
Behavioral: Intra-articular Injection

Study type

Interventional

Funder types

Other

Identifiers

NCT06301620
GUANJIEQIANG

Details and patient eligibility

About

The goal of this clinical trial is to study about the clinical effect of Intra-articular Injection on Temporomandibular Joint Dysfunction

The main question it aims to answer is:

• Can Intra-articular Injection help improve the Temporomandibular Joint Dysfunction Participants will be randomly assigned into the experimental group and the control group, all under comprehensive treatment. The experimental group will be given Intra-articular Injection additionally, The study lasts 15 days for each patient. Researchers will compare the assessments between the two groups to see if Intra-articular Injection can help improve the Temporomandibular Joint Dysfunction

Full description

The background of Temporomandibular Joint Dysfunction is that it is one of the common diseases in the oral and maxillofacial region, and it is the most common among temporomandibular joint diseases. It is more prevalent in young adults, with the highest prevalence rate at 20-30 years old.

The goal of this clinical trial is to study about the clinical effect of Intra-articular Injection on Temporomandibular Joint Dysfunction

The main question it aims to answer is:

• Can Intra-articular Injection help improve the Temporomandibular Joint Dysfunction Participants will be randomly assigned into the experimental group and the control group, all under comprehensive treatment. The experimental group will be given Intra-articular Injection additionally, The study lasts 15 days for each patient. Researchers will compare the assessments between the two groups to see if Intra-articular Injection can help improve the Temporomandibular Joint Dysfunction

Enrollment

88 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Presence of significant temporomandibular disorder clinical symptoms.
  • Meeting the diagnostic criteria for Temporomandibular Joint Dysfunction and confirmed by X-ray examination.
  • Patients voluntarily participate in this study and provide signed informed consent.
  • Normal cognitive function

Exclusion criteria

  • Rheumatic, rheumatoid, or other severe systemic diseases.
  • Infectious temporomandibular joint arthritis or joint tumors.
  • Individuals who have recently received joint injection treatment or photodynamic therapy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

88 participants in 2 patient groups

Routine rehabilitation treatment+Intra-articular Injection
Experimental group
Description:
The patients receive a 15-day treatment and are required to stay in the hospital during this period. Patients in the experimental group are given routine rehabilitation treatment and intra-articular injections. Lidocaine is used as the injected medication at a dose of 2ml, administered once every 5 days for a total of three injections.
Treatment:
Behavioral: Routine rehabilitation treatment
Behavioral: Intra-articular Injection
Routine rehabilitation treatment
Active Comparator group
Description:
The patients receive a 15-day treatment and are required to stay in the hospital during this period. Patients are given routine rehabilitation treatment.
Treatment:
Behavioral: Routine rehabilitation treatment

Trial contacts and locations

1

Loading...

Central trial contact

Lavie Ce, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems